Long-term outcomes following salvage surgery for locally recurrent rectal cancer: A 15-year follow-up study. Issue 6 (June 2020)

• Record Type: Journal Article
• Authors: Cyr, David P.; Zih, Francis SW.; Wells, Bryan J.; Swett-Cosentino, Jossie; Burkes, Ronald L.; Brierley, James D.; Cummings, Bernard; Smith, Andrew J.; Swallow, Carol J.
• Is Part Of: European journal of surgical oncology. Volume 46:Issue 6(2020)
• Page Start: 1131
• Page End: 1137
• Publication Date: 2020-06
• Subjects: Rectal cancer -- Local recurrence -- Resection -- Salvage surgery -- Long-term survival; Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2020.02.032
• Languages: English
• ISSNs: 0748-7983

Abstract

Abstract: Background: Locally recurrent rectal cancer (LRRC) is a complex problem requiring multidisciplinary consultation and specialized surgical care. Given the paucity of published longer-term survival data, skepticism persists regarding the benefit of major extirpative surgery. We investigated ultra-long-term (~15 years) outcomes following radical resection of LRRC and sought relevant clinicopathologic prognostic variables. Methods: A cohort of 52 consecutive patients who underwent resection of LRRC at our institution between 1997 and 2005 were followed with serial exams and imaging up to the point of death, or 30/06/2019. Results: Median follow-up time was 16.5 years (9.9–18.3) for patients who were alive at last follow-up; only one patient was lost to follow-up, at 9.9 years. For the entire cohort of 52 patients, disease-specific survival (DSS) at 5, 10, and 15 years following salvage surgery was 41%, 33%, and 31%, respectively. All patients who had distant metastatic disease at the time of LRRC resection (n = 6) subsequently died of cancer, at a median of 21 months (4−46). In those without distant metastases at time of salvage surgery (n = 46), DSS at 5, 10, and 15 years was 47%, 38%, and 35%, respectively, median 60 months. Negative resection margin (R0) was independently predictive of superior outcomes. In patients with M0 disease who had R0 resection (n = 37), DSS at 5, 10 and 15 years was 58%, 47%, and 44%, respectively, median 73 months. No patient developed re-recurrence after 5.5 years. Conclusions: This study demonstrates exceptionally durable long-term cancer-free survival following salvage surgery for LRRC, indicating that cure is possible.